Safety and feasibility of cold‐stored uncrossmatched whole blood transfusion in civilian non‐trauma patients
Transfusion · 2026
DOI: 10.1111/trf.70145 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transfusion, 2026. Verfasst von Emmanuel A Fadeyi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology & Laboratory Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA. Hauptthemen laut MEDLINE: Blood Transfusion, Hemorrhage, Blood Preservation. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
There is evidence in the civilian population that resuscitation using group O low titer whole blood (WB) may provide survival benefits to traumatically injured patients. However, there is limited information in the literature concerning the use of WB in non‐trauma patients requiring resuscitation. The outcome of patients presenting with non‐traumatic hemorrhage who received WB resuscitation was investigated. Study design and methods Existing data of all adults ≥18 years old who received WB transfusion either as massive transfusion or emergency release blood transfusion at our institution were reviewed from April 2018 to December 2024. Non‐trauma patients were stratified into three indication categories (GI bleed, nonoperative hemorrhage, and operative hemorrhage). The primary outcome measure was mortality at 24 h.
Results
A total of 331 non‐trauma patients received WB in our cohort. The overall 24‐h mortality rate was 18.7%, whereas the overall in‐hospital 30‐day mortality was 46.8%. The most common etiology of non‐traumatic hemorrhage was GI bleeding (43.8%, n = 145/331). Nonoperative 24‐h mortality was statistically higher than other indication categories. The ICU length of stay and number of WB units transfused was also statistically higher for the operative category. Three patients experienced one allergic and two delayed hemolytic transfusion reactions.
Discussion
This study demonstrates that the use of WB in non‐trauma patients is associated with a decreased 24 h in‐hospital mortality with either operative or GI bleed when compared to nonoperative WB transfusion. Emergent severely hemorrhaging non‐trauma patients can receive WB transfusions safely without any increased transfusion related adverse effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Pathology & Laboratory Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
- Department of Pathology & Laboratory Medicine, Atrium Health Wake Forest Baptist, Winston-Salem, North Carolina, USA.
- Department of Anesthesiology, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
ORCID-Profile: Emmanuel A Fadeyi
Zitieren
APA
Fadeyi, E. A., Cox-Jones, J., Staggs, J., Alwan, A., Saha, A. K., Crosby, A. J., & Pomper, G. J. (2026). Safety and feasibility of cold‐stored uncrossmatched whole blood transfusion in civilian non‐trauma patients. Transfusion. https://doi.org/10.1111/trf.70145
Vancouver
Fadeyi EA, Cox-Jones J, Staggs J, Alwan A, Saha AK, Crosby AJ, et al. Safety and feasibility of cold‐stored uncrossmatched whole blood transfusion in civilian non‐trauma patients. Transfusion. 2026. doi:10.1111/trf.70145
BibTeX
@article{Fadeyi2026,
author = {Fadeyi, Emmanuel A and Cox-Jones, Joshua and Staggs, Jordan and Alwan, Abdelrahman and Saha, Amit K and Crosby, Ashley J and Pomper, Gregory J},
title = {Safety and feasibility of cold‐stored uncrossmatched whole blood transfusion in civilian non‐trauma patients},
journal = {Transfusion},
year = {2026},
doi = {10.1111/trf.70145}
}
EUVIMED